Submit Your Manuscript to JCGB
Your pathway to publishing high-impact cancer genetics and biomarker research with the Journal of Cancer Genetics and Biomarkers.
Fast, Fair, and Impactful Submission Experience
The Journal of Cancer Genetics and Biomarkers (JCGB) is a peer-reviewed, open-access platform that accelerates breakthroughs in cancer genomics, precision biomarkers, and personalised oncology. Our submission workflow is designed for busy research teams: intuitive manuscript intake, responsive editorial triage, expert peer review, and rapid publication upon acceptance. Every article is immediately accessible worldwide, ensuring your findings reach clinicians, translational scientists, and policy leaders without barriers.
1. ManuscriptZone Portal (Preferred)
Submit via JCGB’s secure editorial management system to track progress in real time and communicate directly with editors.
- Portal: https://oap.manuscriptzone.net/auth/login
- Create an account or log in with existing credentials.
- Select “Journal of Cancer Genetics and Biomarkers” from the journal list.
- Indicate article type and, if relevant, the target special issue.
2. Quick Submission Form
Ideal for preliminary submission with limited time. Upload your manuscript and supporting files; the editorial office will create the ManuscriptZone record on your behalf.
- Form: https://openaccesspub.org/manuscript-submission-form
- Attach manuscript, cover letter, and supplementary assets.
- Expect confirmation within 24 hours with your ManuscriptZone tracking ID.
3. Direct Email Intake
For teams facing firewall restrictions or submitting large multimedia packages. Send materials via email; JCGB staff will initiate the submission and guide you through next steps.
- Email: [email protected]
- Subject line: “JCGB Submission – [Article Title]”.
- Include author details, abstract, keywords, and any special handling requests.
Ensure your manuscript aligns with JCGB standards prior to submission. Use this checklist alongside the Instructions for Author.
- Article Structure: Title page, abstract (≤250 words), keywords (5–12), introduction, methods, results, discussion, conclusions, acknowledgments, conflict of interest, funding, references.
- File Formats: Main document in Microsoft Word (.docx) or LaTeX (zip file with PDF). Figures in TIFF/PNG (≥300 dpi) or vector formats (AI, EPS). Tables embedded or provided as separate Excel files.
- Reporting Guidelines: Include completed checklists (e.g., CONSORT, PRISMA, STARD, REMARK) as supplementary files where applicable.
- Data Availability: Provide repository links (GEO, SRA, dbGaP, EGA, Zenodo, Figshare) or a statement explaining controlled access. List accession numbers in the manuscript.
- Code Sharing: Link version-controlled repositories (GitHub, GitLab) and specify licenses (MIT, Apache 2.0, etc.). For proprietary tools, offer executable notebooks or virtual machine images when possible.
- Ethics Approval: Cite institutional review board (IRB) approvals, informed consent procedures, animal care protocols, material transfer agreements, and data governance frameworks.
- Conflict & Funding: Disclose financial relationships, advisory roles, intellectual property interests, and grant numbers. Use the dedicated sections in ManuscriptZone.
Original Research
Full-length articles presenting novel insights into cancer genetics, biomarker discovery, assay validation, or translational implementation.
Rapid Communications
Time-sensitive findings such as emergent resistance mechanisms, breakthrough diagnostic technology, or urgent public health implications.
Reviews & Meta-Analyses
Comprehensive syntheses of state-of-the-art topics, including scoping reviews and systematic analyses that guide future research investments.
Methods & Protocols
Detailed experimental or computational methodologies, benchmarking studies, and reproducibility toolkits that raise rigour standards.
Clinical Case Series & Practice Innovations
Real-world applications of biomarker-driven care, adaptive clinical decision-making, or decentralized diagnostics programs.
Perspective & Policy Analysis
Thought leadership exploring ethical, regulatory, and socio-economic dimensions of cancer genomics and precision medicine.
JCGB operates a single-blind peer review model with optional double-blind review upon request. Our process emphasises constructive feedback and timely decisions.
- Editor Assignment: Submissions are assigned to section editors specialising in genomics, biomarker analytics, translational oncology, or clinical research.
- Reviewer Selection: We invite 2–3 reviewers based on expertise, track record, and absence of conflicts. Reviewer diversity in geography and career stage is prioritised.
- Review Focus: Novelty, rigor, reproducibility, data transparency, and translational relevance.
- Decision Outcomes: Accept, minor revision, major revision, or decline with transfer recommendations. Detailed decision letters guide revisions.
- Revision Cycles: Most manuscripts undergo one revision. Additional cycles are reserved for substantial updates with clear value.
| Stage | Target Duration | Author Responsibilities | JCGB Actions |
|---|---|---|---|
| Submission Confirmation | Within 24 hours | Check inbox for ManuscriptZone ID; verify metadata | Assign handling editor, initiate compliance checks |
| Triage Review | 5–7 business days | Respond to queries on scope, format, or documentation | Validate article fit, ensure guidelines satisfied |
| Peer Review Round 1 | 21–28 days | Monitor portal, prepare for potential revisions | Coordinate reviewers, send reminders, synthesise feedback |
| Revision Phase | 14–35 days | Submit tracked changes and response letter | Reassess revisions, consult reviewers as needed |
| Final Decision | 5 days post-revision | Complete final edits, sign publication forms | Issue acceptance or further guidance |
| Production & Proofing | 7–10 days | Return proof corrections within 48 hours | Publish article online, assign DOI, update indexes |
Language Editing & Formatting
Enhance clarity and consistency with the JCGB Language Editing Service. Packages include scientific copyediting, journal formatting, and figure polishing.
Pre-Submission Consultation
Send a synopsis or abstract to [email protected] for scope feedback. We can suggest suitable article types or special issues and provide checklists.
Data & Code Hosting Support
JCGB partners with repositories and offers guidance on de-identification, metadata standards, and licensing. Request assistance when preparing large genomic or imaging datasets.
Promotional Toolkit
Post-acceptance, authors receive social media templates, press release drafts, and infographic layouts to disseminate their findings effectively.
- Authorship: Follow the ICMJE criteria. Confirm author order and contributions within ManuscriptZone.
- Plagiarism Screening: JCGB uses iThenticate to verify originality. Manuscripts with significant overlap are returned or declined.
- Human & Animal Research: Provide IRB/IACUC approvals, trial registration numbers, and consent statements. For indigenous genomic data, include community consent protocols.
- Data Corrections: JCGB supports post-publication updates, corrections, and retractions in line with COPE guidelines.
JCGB is open access. Accepted manuscripts incur an Article Processing Charge (APC) of $2,199 USD to cover peer review coordination, editorial production, hosting, and indexing.
- APC details: JCGB Article Processing Charges
- Waivers: Up to 25% reduction through the Waiver Program 2025, prioritising early-career investigators and low- and middle-income country authors.
- Membership: Research groups can offset APCs via JCGB Membership plans.
- Alternative funding: Provide grant information or institutional agreements during submission to align invoicing with procurement policies.
Instructions for Author
Detailed formatting requirements, reference styles, and sample templates.
Review InstructionsEditorial Policies
Understand peer review standards, confidentiality, and corrections policy.
Explore PoliciesData Archiving Permissions
Guidance on repository selection, controlled access, and citation practices.
Read Data PolicyPublishing is just the beginning. JCGB fosters an ecosystem of collaboration:
- Participate in webinars featuring authors and guest editors discussing new diagnostics, AI models, or policy implications.
- Join LinkedIn discussions moderated by JCGB to share implementation stories and seek collaborators for multi-centre trials.
- Volunteer as a reviewer via the Reviewer Register to influence the scientific agenda and enhance your editorial skills.
- Submit proposals for special issues to spotlight emerging topics. See Proposing a Special Issue.
Submit to JCGB Today
Ready to share your breakthrough? Upload your manuscript via ManuscriptZone, or contact us for personalised assistance. JCGB is committed to amplifying credible science that transforms cancer care.
Last updated: September 2025. JCGB reviews submission guidelines annually to reflect evolving standards in cancer genomics and open science.
